Mannitol Augments the Effects of Systemical Stem Cell Transplantation without Increasing Cell Migration in a Stroke Animal Model
Conclusion:Combinatorial treatment with mannitol and hADSC transplantation may have better therapeutic potential than hADSC monotherapy for ischemic stroke.
Source: Tissue Engineering and Regenerative Medicine - Category: Biotechnology Source Type: research
More News: Biotechnology | Brain | Calcium | Ischemic Stroke | Neurology | Stem Cell Therapy | Stem Cells | Stroke | Study | Transplants